Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 09, 2023

BUY
$44.2 - $50.2 $200,137 - $227,305
4,528 New
4,528 $206,000
Q4 2022

Jan 30, 2023

BUY
$41.39 - $81.0 $70,901 - $138,753
1,713 Added 58.42%
4,645 $209,000
Q3 2022

Oct 21, 2022

BUY
$72.36 - $113.1 $212,159 - $331,609
2,932 New
2,932 $212,000
Q1 2021

May 12, 2021

SELL
$101.51 - $125.27 $2.37 Million - $2.92 Million
-23,308 Closed
0 $0
Q4 2020

Feb 04, 2021

SELL
$85.88 - $105.36 $1.09 Million - $1.34 Million
-12,706 Reduced 35.28%
23,308 $2.43 Million
Q3 2020

Oct 23, 2020

SELL
$72.74 - $92.5 $432,366 - $549,820
-5,944 Reduced 14.17%
36,014 $3.09 Million
Q2 2020

Aug 03, 2020

SELL
$48.02 - $79.04 $76,880 - $126,543
-1,601 Reduced 3.68%
41,958 $3.08 Million
Q4 2019

Feb 10, 2020

SELL
$47.06 - $56.64 $48,707 - $58,622
-1,035 Reduced 2.32%
43,559 $2.45 Million
Q3 2019

Oct 23, 2019

SELL
$47.45 - $58.05 $4,555 - $5,572
-96 Reduced 0.21%
44,594 $2.13 Million
Q2 2019

Jul 18, 2019

BUY
$39.26 - $54.21 $297,512 - $410,803
7,578 Added 20.42%
44,690 $2.42 Million
Q1 2019

Apr 22, 2019

SELL
$29.84 - $43.92 $78,001 - $114,806
-2,614 Reduced 6.58%
37,112 $1.51 Million
Q4 2018

Jan 10, 2019

BUY
$29.95 - $46.34 $1,976 - $3,058
66 Added 0.17%
39,726 $1.81 Million
Q4 2018

Jan 10, 2019

SELL
$29.95 - $46.34 $1,976 - $3,058
-66 Reduced 0.17%
39,660 $1.24 Million
Q3 2018

Oct 17, 2018

SELL
$40.12 - $45.55 $2,487 - $2,824
-62 Reduced 0.16%
39,726 $1.81 Million
Q2 2018

Jul 19, 2018

SELL
$38.72 - $42.52 $100,633 - $110,509
-2,599 Reduced 6.13%
39,788 $1.67 Million
Q1 2018

May 16, 2018

BUY
$39.4 - $47.39 $347,783 - $418,311
8,827 Added 26.3%
42,387 $1.74 Million
Q4 2017

Jan 25, 2018

SELL
$37.27 - $43.02 $993,357 - $1.15 Million
-26,653 Reduced 44.26%
33,560 $1.38 Million
Q3 2017

Oct 31, 2017

BUY
$33.75 - $41.67 $2.03 Million - $2.51 Million
60,213
60,213 $2.4 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Foundry Partners, LLC Portfolio

Follow Foundry Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Foundry Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Foundry Partners, LLC with notifications on news.